Stock ORY ORYZON GENOMICS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Charts Oryzon Genomics S.A.

Equities

ORY

ES0167733015

Market Closed - BME
Other stock markets
 11:35:26 2024-04-26 am EDT 		5-day change 1st Jan Change
2 EUR +0.91% Intraday chart for Oryzon Genomics S.A. +5.60% +5.93%
Apr. 22 Oryzon Genomics, S.A. Secures Another Important Patent for its Lead CNS Asset, Vafidemstat CI
Apr. 08 ORYZON Announces U.S. FDA Clearance of CTEP-CRADA Phase I/II Clinical Trial Sponsored by NCI for Iadademstat Plus Immune Checkpoint Inhibitors in 1L Extensive Stage Small Cell Lung Cancer CI

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Neutral

Neutral

Neutral

Resistance 2.080 2.215 2.215
Spread/Res.-3.85%-9.71%-9.71%
Spread/Supp.+16.96%+24.84%+20.63%
Support 1.710 1.602 1.658

Technical Rankings Surperformance

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
  1. Stock Market
  2. Equities
  3. ORY Stock
  4. Charts Oryzon Genomics S.A.